Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning (NCT04515810)
Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning
🩺 Plain-English Summary (8th-Grade Level)
This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.
Who can join: Review the eligibility criteria below.
Location: Northwell Health — Manhasset, New York
Age range: 18 Years
🧪 Interventions in This Study
- Internet-Based Intervention (OTHER)
- Best Practice (OTHER)
- Telephone-Based Intervention (OTHER)
- Questionnaire Administration (OTHER)
- Post-intervention qualitative feedback interview (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Northwell Health — Manhasset, New York
- Mount Sinai Hospital — New York, New York
- NYP/Weill Cornell Medical Center — New York, New York
- Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (206) 667-1565
Email: cdelossa@fredhutch.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Locally Advanced Malignant Solid Neoplasm
- Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial — Birmingham, Alabama
- Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies — Duarte, California
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial — Bethesda, Maryland
- Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors — Houston, Texas
Explore by condition: All Locally Advanced Malignant Solid Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.